CT

Cidara Therapeutics

CDTX
NASDAQHealth Care

Income Statement

Total Revenue$1.28M
Gross Profit$1.28M
Operating Income$-176.1M
EBITDA$-168.55M
EBIT$-169.83M
Pre-tax Income$-184.8M
Net Income$-169.83M

Balance Sheet

Cash Equivalent$129.24M
Total Debt$4.12M
Book Value$98.02M
Book Value Per Share16.92

Key Ratios

Return on Equity (ROE)-103.99%
Return on Assets (ROA)-79.06%
Return on Invested Capital (ROI)-103.63%
Net Profit Margin-13319.76%
Current Ratio4.25
Quick Ratio3.99
Long-Term Debt / Equity0.00